PND44 Assessing Variations in Transitions in Employment in Relapsing-Remitting Multiple Sclerosis Patients Treated With Either Laquinimod, Interferon Beta 1-a or Placebo- Expoloratory Evidence From the United States Substudy of Bravo
Jun 1, 2012, 00:00 AM
10.1016/j.jval.2012.03.803
https://www.valueinhealthjournal.com/article/S1098-3015(12)00868-6/fulltext
Section Title :
Neurological Disorders
Section Order :
286
First Page :
A149
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)00868-6&doi=10.1016/j.jval.2012.03.803